DR. MARTIN FLEISHER, PH.D.
Technologists at York Ave, New York, NY
License number
New York B10329
Category
Technologists
Type
Chemistry
Address
Address
2
1275 York Ave, New York, NY 10021
45 Knott Dr, Glen Cove, NY 11542
45 Knott Dr, Glen Cove, NY 11542
Phone
(212) 639-8757
(516) 671-3621
(516) 671-3621
Personal information
See more information about MARTIN FLEISHER at radaris.comName
Address
Phone
150 Claremont Ave APT 4G, New York, NY 10027
176 E 71St St, New York, NY 10021
44 Morningside Dr, New York, NY 10025
45 Knott Dr, Glen Cove, NY 11542
560 Riverside Dr APT 16A, New York, NY 10027
Organization information
See more information about MARTIN FLEISHER at bizstanding.comMARTIN FLEISHER, J.D., PC
176 E 71 St #2B, New York, NY 10021
Registration:
Oct 22, 2003
State ID:
2968001
Business type:
DOMESTIC PROFESSIONAL CORPORATION
Martin Fleisher, 176 E 71 St #2B, New York, NY 10021 (Physical)
Professional information
Managing Director Of Dearborn Capital Partners Llc
Position:
Owner at Dearborn Capital Partners, Owner at Martin Fleisher, JD PC
Location:
Greater New York City Area
Industry:
Financial Services
Work:
Dearborn Capital Partners
since Nov 2007
-
Owner
Martin Fleisher, JD PC
since 1992
-
Owner
Kramer Levin Naftalis & Frankel LLP
Sep 1984 - Jun 1992
-
Associate
Education:
New York University School of Law 1981 - 1984
JD, Law Swarthmore College 1976 - 1980
BA, Philosophy
JD, Law Swarthmore College 1976 - 1980
BA, Philosophy
Interests:
tournament bridge
Director At Mskcc
Position:
Director at MSKCC
Location:
Greater New York City Area
Industry:
Hospital & Health Care
Work:
MSKCC
-
Director
Martin E. Fleisher, New York NY - Lawyer
Address:
Martin Fleisher
7 Times Sq FL 27, New York 10036
(212) 767-7307
7 Times Sq FL 27, New York 10036
(212) 767-7307
Licenses:
New York - Currently registered 1985
Education:
New York University School of Law
Diagnostic Device For Fecal Occult Blood And Method Of Use
US Patent:
4333734, Jun 8, 1982
Filed:
Oct 8, 1980
Appl. No.:
6/195220
Inventors:
Martin Fleisher - Glen Cove NY
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
G01N 2178, G01N 3372
US Classification:
23230B
Abstract:
Diagnostic test device for fecal occult blood utilizing a test matrix such as paper impregnated with guaiac. False-positive results in the presence of peroxidases are prevented by adding to the matrix a compound that cleaves protein hydrogen bonds such as guanidine hydrochloride and a chelating agent that binds calcium and/or magnesium such as EDTA.
Sampling System For Stool Analysis
US Patent:
4492124, Jan 8, 1985
Filed:
Jul 30, 1982
Appl. No.:
6/404201
Inventors:
Martin Fleisher - Glen Cove NY
Sidney J. Winawer - New York NY
Sidney J. Winawer - New York NY
Assignee:
Memorial Hospital for Cancer and Allied Diseases - New York NY
International Classification:
G01N 108
US Classification:
7386444
Abstract:
A sampling system for stool analysis provides an elongated handle and a cylindrical coring device, said handle including means for releasibly holding said coring device. The coring device is inserted into the stool to collect a representative sample. The sample is removed for analysis, as required.
Solvent System For Peroxidase Inhibitor Reagent For Fecal Occult Blood Determinations
US Patent:
4493892, Jan 15, 1985
Filed:
Dec 20, 1982
Appl. No.:
6/451526
Inventors:
Martin Fleisher - Glen Cove NY
Assignee:
Memorial Hospital for Cancer & Allied Diseases - New York NY
International Classification:
C12Q 128, G01N 3372
US Classification:
435 28
Abstract:
A process and reagent for determining the presence of fecal occult blood in a test sample using a guaiac-peroxidase test matrix and a means for inhibiting peroxidase enzyme interferences which combines the partial denaturing of peroxidase enzyme protein using a protein-hydrogen bond cleaving agent, with the removal of metals necessary for efficient peroxidase enzyme activity wherein the improvement comprises dissolving said reagent for cleaving protein-hydrogen bonds in an alcohol-water solvent before adding said reagent to the sample.
Breast Cyst Fluid Screening Method For Cancer Risk Assessment
US Patent:
4695471, Sep 22, 1987
Filed:
Jul 30, 1984
Appl. No.:
6/635846
Inventors:
Martin Fleisher - Glen Cove NY
H. Leon Bradlow - Holliswood NY
Morton K. Schwartz - Tarrytown NY
H. Leon Bradlow - Holliswood NY
Morton K. Schwartz - Tarrytown NY
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
G01N 3348
US Classification:
436 64
Abstract:
A method for screening breast cyst fluid to identify patients having a high risk of developing breast cancer, comprising the steps of measuring the chloride ion content of breast cyst fluid aspirated from the patient; and correlating the chloride ion concentration with the risk of developing breast cancer.